SequelSEC

BIO-PATH HOLDINGS, INC. BPTH

Pharmaceutical Preparations · CIK 0001133818 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2018-12-31
Operating income
-$8.59M
Fiscal year ended 2018-12-31
Free cash flow
-$6.14M
Fiscal year ended 2018-12-31

Valuation, from the filing

Public float$5.04MMarket value of stock held by non-affiliates, as stated on the cover page for 2024-06-30
Float per share$0.61Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-06-30, not today.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth-100.0%0th
Current ratio1.61x24th

BIO-PATH HOLDINGS, INC. (BPTH) reported revenue of $0 and net income of -$8.58M for the fiscal year ended 2018-12-31. This page shows 5 annual periods of income statement, balance sheet and cash flow figures normalized from BIO-PATH HOLDINGS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

BIO-PATH HOLDINGS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$0$37.00K$13.00K$0$0
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$8.59M-$8.97M-$8.48M-$5.48M-$4.54M
Net income-$8.58M-$7.02M-$6.75M-$5.47M-$4.52M
Research & development$4.60M$5.48M$5.47M$3.02M$1.63M
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax income-$8.58M-$7.02M-$6.75M-$5.47M-$4.56M
Income tax expense$0$0$0$0$0
Diluted EPSUnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$3.38M$3.52M$3.01M$2.46M$2.72M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

BIO-PATH HOLDINGS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312016-12-312015-12-312014-12-31
Cash & equivalentsUnavailableUnavailableUnavailableUnavailableUnavailable
Total assets$2.54M$8.86M$12.20M$10.76M$15.48M
Current assets$2.14M$7.44M$10.65M$9.59M$14.11M
Total liabilities$1.33M$791.00K$3.96M$937.00K$561.97K
Current liabilities$1.33M$791.00K$1.05M$937.00K$561.97K
Total equity incl. NCI$1.22M$8.07M$8.24M$9.82M$14.92M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailable$0$0
Accounts payable$587.00K$52.00K$69.00K$54.00K$41.03K

Cash flow

BIO-PATH HOLDINGS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312016-12-312015-12-312014-12-31
Operating cash flow-$6.12M-$7.96M-$8.15MUnavailableUnavailable
Capital expenditures$17.00K$538.00K$338.00K$0$123.00K
Investing cash flow-$17.00K-$538.00K-$338.00KUnavailableUnavailable
Financing cash flow$1.18M$5.08M$9.01MUnavailableUnavailable
Net change in cash-$4.96MUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$554.00K$793.00K$784.00K$369.00K$404.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

BIO-PATH HOLDINGS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312016-12-312015-12-312014-12-31
Free cash flow-$6.14M-$8.50M-$8.49MUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailable-24232.4%-65192.3%UnavailableUnavailable
FCF marginUnavailable-22959.5%-65276.9%UnavailableUnavailable
SBC / revenueUnavailable2143.2%6030.8%UnavailableUnavailable
Current ratio1.61x9.40x10.15x10.24x25.12x
Revenue YoY growth-100.0%184.6%UnavailableUnavailableUnavailable
Net marginUnavailable-18981.1%-51923.1%UnavailableUnavailable
R&D / revenueUnavailable14810.8%42107.7%UnavailableUnavailable
CapEx / revenueUnavailable1454.1%2600.0%UnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BPTH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-05-20View SEC filing
10-Q · Filed 2026-01-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-03-27View SEC filing
10-Q · Filed 2024-11-14View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.